Found: 13
Select item for more details and to access through your institution.
Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Oral Formulations of Calcium Dobesilate Capsules in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 360, doi. 10.1002/cpdd.1376
- By:
- Publication type:
- Article
Cardiovascular Evaluation of Etrasimod, a Selective Sphingosine 1‐phosphate Receptor Modulator, in Healthy Adults: Results of a Randomized, Thorough QT/QTc Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 326, doi. 10.1002/cpdd.1388
- By:
- Publication type:
- Article
Physiologically Based Pharmacokinetic Absorption Model for Pexidartinib to Evaluate the Impact of Meal Contents and Intake Timing on Drug Exposure.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 440, doi. 10.1002/cpdd.1385
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Etripamil, an Intranasally Administered, Fast‐Acting, Nondihydropyridine Calcium Channel Blocker.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 367, doi. 10.1002/cpdd.1383
- By:
- Publication type:
- Article
Results from a Phase 1 Study Assessing the Pharmacokinetics of the Aldosterone Synthase Inhibitor Baxdrostat in Participants with Varying Degrees of Renal Function.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 410, doi. 10.1002/cpdd.1371
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of Voriconazole for Injection in Two Preparations in Chinese Healthy Adult Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 404, doi. 10.1002/cpdd.1370
- By:
- Publication type:
- Article
Population Pharmacokinetic and Pharmacodynamic Modeling of Romiplostim Biosimilar GP40141 and Reference Product in Healthy Volunteers to Evaluate Biosimilarity.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 419, doi. 10.1002/cpdd.1367
- By:
- Publication type:
- Article
Reduced Plasma Levodopa Fluctuations with More Frequent Administration of a Novel Carbidopa/Levodopa Functionally Scored Tablet.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 380, doi. 10.1002/cpdd.1360
- By:
- Publication type:
- Article
Mass Balance and Metabolite Profile after Single and Multiple Oral Doses of Pritelivir in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 389, doi. 10.1002/cpdd.1358
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of a Novel Oral Phosphodiesterase 4 Inhibitor, ME3183: First‐in‐Human Phase 1 Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 341, doi. 10.1002/cpdd.1351
- By:
- Publication type:
- Article
Bioequivalence of 240 mg Apalutamide Tablets and Preparation in Aqueous Food Vehicles for Alternative Administration.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 432, doi. 10.1002/cpdd.1346
- By:
- Publication type:
- Article
A Randomized, Single‐Dose, Parallel‐Controlled Phase 1 Clinical Comparison of an Omalizumab Biosimilar Candidate with Reference Omalizumab in Healthy Chinese Male Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 349, doi. 10.1002/cpdd.1350
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 321, doi. 10.1002/cpdd.1117
- Publication type:
- Article